February 18th, 2016
Podcast 195: Pioglitazone for secondary prevention?
Pioglitazone, long known to increase insulin sensitivity, has been “mostly relegated to use in unusual conditions such as lipodystrophies” after its drug class, the thiazolidinediones, “fell from grace” in the words of our guest. Dr. Clay Semenkovich has just written an editorial comment on a study in the New England Journal of Medicine. That study […]
October 6th, 2015
Podcast 186: Stop supplementing calcium!
Two analyses in the BMJ show little or no benefit from loading up older patients with calcium — indeed, the bad side effects of doing so (kidney stones and cardiovascular problems, to name two) outweigh the benefits. Our conversation with Dr. Mark Bolland should offer reassurance to clinicians and their patients that a normal diet will […]